{
    "address": "Erik Dahlbergsgatan 11A",
    "city": "Goeteborg",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W96156109",
    "description": "Toleranzia AB is a biotechnology company. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-16. The firm's main project is aimed against an autoimmune nerve-muscle disease and myasthenia gravis. The Company\u2019s platform technology enables the development of therapies targeting the cause of the disease, which in the current situation is the usual treatment.",
    "employeeTotal": "",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Biotechnology",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Biotechnology",
    "gsector": "Health Care",
    "gsubind": "Biotechnology",
    "ipo": "2015-12-16",
    "isin": "SE0007438577",
    "logo": "",
    "marketCapitalization": 70.10639,
    "naics": "Scientific Research and Development Services",
    "naicsNationalIndustry": "Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)",
    "naicsSector": "Professional, Scientific, and Technical Services",
    "naicsSubsector": "Professional, Scientific, and Technical Services",
    "name": "Toleranzia AB",
    "phone": "46763199898.0",
    "sedol": "BYQ5LG9",
    "shareOutstanding": 54.346041,
    "state": "VASTRA GOTALANDS",
    "ticker": "TOL.ST",
    "weburl": "https://www.toleranzia.com/"
}